Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients

2013307 citationsJournal Articlegreen Open Access

Authors

Carlos Benítez · Hospital Clínic de Barcelona

María‐Carlota Londoño · Hospital Clínic de Barcelona

Rosa Miquel · Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Tommaso Maria Manzia · University of Rome Tor Vergata

Juan G. Abraldeṣ · Hospital Clínic de Barcelona

Juan José Lozano · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Abstract

When conducted at late timepoints after transplantation, immunosuppression withdrawal is successful in a high proportion of carefully selected liver recipients. A combination of clinical parameters could be useful to predict the success of this strategy. Additional prospective studies are now needed to confirm these results and to validate clinically applicable diagnostic biomarkers.

Topics & Keywords

Renal Transplantation Outcomes and Treatments Organ Transplantation Techniques and Outcomes Neurological Complications and Syndromes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology

Volume 58, Issue 5, pp. 1824-1835

DOI: 10.1002/hep.26426

Field-Weighted Citation Impact: 19.09